AR-65

N/A

Report date: 2025/01/26 15:07:17

Base Information

Drug NameAR-65
Drug Alias Nameimmunoproteasome inhibitor (University of Kentucky/Konkuk University)AR-65
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kentucky
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A